Close Menu

Precision Oncology Business News

Financial news, mergers and acquisitions, partnerships, and alliances.

The pavilion and precision medicine programs are supported by $40 million in philanthropic funding from Mort Harris in honor of his late wife Brigitte.

On Thursday, Predictive Oncology closed another direct offering initiated earlier in the week, raising $2.2 million.

The final decision includes some changes, most notably removing requirements for guideline inclusion, but retains its technical performance benchmarks.

The company has reached agreements with investors for a direct offering of 2.2 million shares at $1 per share, for gross proceeds of about $2.2 million.